Global Health Economics Director, CCVP

Director, Health Economics Join us in pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our inspiring and caring environment forms a global community that celebrates diversity and individuality. We encourage you to step beyond your comfort zone, offering resources and flexibility to foster your professional and personal growth, all while valuing your unique contributions. The Director, Health Economics is a senior cross‑functional leadership role responsible for developing and executing global growth strategy and long‑range financial and value planning for Advanced Oncology Solutions Cancer Care Value Programs (CCVP), including radiation oncology, theranostics, and related products and services. This role leads the generation, translation, and communication of robust clinical and economic evidence to demonstrate measurable value to CCVP advisory boards, payers, hospital procurement committees, HTA bodies, government agencies, and clinical partners worldwide. In addition, the Director is accountable for establishing and governing a performance measurement framework, including the development, monitoring, and continuous optimization of key performance indicators (KPIs) that track financial performance, value realization, market access success, and partnership outcomes across CCVP initiatives. Reporting to the Global VP of Cancer Care Value Programs, this leader collaborates closely with Sales and Services Teams, Digital Health and AI Teams, Global Marketing, Medical Affairs, Government Affairs, Reimbursement, Clinical Research, Finance, and Commercial teams to directly enable revenue growth, market access, and scalable value partnerships. Strategy, Financial Planning & KPI Governance Develop and lead the multi‑year CCVP strategic and financial roadmap, ensuring alignment with corporate growth, profitability, and market expansion objectives. Define, implement, and continuously refine a global KPI framework to measure: Revenue growth and margin performance of CCVP deals Value realization for customers (e.g., cost savings, throughput, outcomes) Market access milestones (coverage, reimbursement levels, policy wins) Adoption and utilization rates of oncology solutions Establish standardized dashboards and reporting cadence (monthly, quarterly, annual) to track performance against KPIs and provide actionable insights to executive leadership. Partner with Finance to integrate KPIs into budgeting, forecasting, and long‑range planning processes, ensuring alignment between strategic objectives and financial outcomes. Lead performance reviews of CCVP partnerships, identifying risks, opportunities, and corrective actions to optimize ROI. Economic Modeling & Value Analytics Build health‑system‑specific economic models and ROI frameworks to support large‑scale Value Partnership deals, including multi‑year agreements with IDNs and government health authorities. Design and oversee advanced health economic models, including: Cost‑effectiveness analyses (CEA) Budget impact models (BIM) Cost‑comparison and total cost of care analyses Hospital‑based HTA models Define and track model performance KPIs, including accuracy of forecasts vs. realized outcomes and model adoption by commercial teams. Translate modeling outputs into quantifiable performance metrics that can be tracked post‑implementation to validate value delivery. Evidence Generation & Outcomes Measurement Partner with Clinical Research and Medical Affairs to design real‑world evidence (RWE) and outcomes studies aligned to payer and HTA expectations. Define measurable clinical, operational, and economic endpoints and embed them into longitudinal KPI tracking frameworks. Develop and oversee processes to monitor real‑world performance vs. projected value hypotheses, ensuring continuous feedback into strategy and modeling. Value Communication & Market Enablement Develop compelling value narratives, economic tools, and payer‑facing materials for CCVP solutions (e.g., radiation therapy, theranostics). Ensure all value propositions are supported by clearly defined, trackable KPIs that resonate with stakeholders (e.g., cost per patient, improved outcomes, system efficiency gains). Partner with Global Commercial Marketing to integrate KPI‑driven value messaging into product launches and competitive positioning strategies. Market Access & Policy Impact Support reimbursement strategy and coding initiatives (e.g., CPT/APC codes), collaborating with Government Affairs on CMS engagement and advocacy. Define and monitor market access KPIs, including: Coverage decisions Reimbursement levels Policy adoption timelines Track and report the financial and strategic impact of market access wins on CCVP performance. Digital Health, AI & Performance Analytics Collaborate with Digital Health and AI teams to develop and validate outcomes evidence for AI‑driven oncology solutions and workflow optimization tools. Inform data‑driven KPI tracking systems leveraging digital tools and analytics platforms to provide real‑time insights into performance. Drive adoption of advanced analytics to enable predictive performance monitoring and continuous improvement of CCVP offerings. Cross‑Functional Leadership & Governance Serve as a strategic partner across functions, ensuring alignment on goals, metrics, and performance tracking. Lead governance forums to review KPIs, assess progress, and drive decision‑making across global stakeholders. Build a culture of data‑driven accountability and performance management within the CCVP organization. Qualifications Advanced degree in a health, business, or quantitative discipline with direct application to healthcare economics, finance, or outcomes measurement. MBA with 10+ years of progressive healthcare finance leadership within large, complex IDNs. 8+ years of progressive experience in strategic healthcare finance, health economics, or outcomes research; demonstrated leadership scope equivalent to director level owning multi‑hundred‑million‑dollar P&Ls, advising C‑suite executives, and driving enterprise decision‑making. Demonstrated expertise building sophisticated financial models for complex oncology programs including cost‑per‑case analyses, ROI and pro‑forma models, multi‑scenario forecasting, budget impact frameworks, and service line economics. Proficiency in advanced Excel, BI tools (Power BI, Essbase, or equivalent), and data visualization. Deep knowledge of U.S. healthcare economics and reimbursement including Medicare/Medicaid (CMS), commercial payers, hospital value analysis committees (VACs), and IDN procurement processes. Hands‑on experience analyzing payer mix impact, reimbursement variability, and revenue optimization across clinical programs. Strong understanding of oncology care pathways and the clinical and operational factors that drive financial performance including radiation oncology economics (linear accelerator utilization, fraction volume, capital intensity), infusion economics, and specialty pharmacy. Proven track record supporting large, complex strategic deals and partnerships with health‑economic evidence and ROI tools including multi‑year, multi‑site program economics, capital investment justification, and performance modeling. Outstanding executive communication and storytelling ability translating complex financial and clinical‑economic data into clear, compelling narratives for CFO, CMO, COO, CEO, and CEO‑level stakeholders. Demonstrated ability to influence strategic decisions without direct authority across matrixed organizations. Experience partnering with clinical and operational leadership on strategic planning including scenario‑based planning, service line growth strategy, access expansion, and efficiency initiatives. International healthcare economics experience and cross‑cultural stakeholder engagement. #J-18808-Ljbffr Siemens Healthineers